Christopher J. Neugent - Mar 1, 2023 Form 4 Insider Report for Cibus, Inc. (CBUS)

Role: Director
Signature: Suzette McNally, Attorney-in-Fact for Christopher J. Neugent
Stock symbol: CBUS
Transactions as of: Mar 1, 2023
Transactions value $: $0
Form type: 4
Date filed: 6/1/2023, 07:11 PM
Previous filing: Jun 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Shares	Change %	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CBUS	Stock Option (Right-to-Buy)	Disposed to Issuer	-7.5K	-100%	0	Mar 1, 2023	Common Stock	7.5K	$4.55	Direct	F1
transaction	CBUS	Stock Option (Right-to-Buy)	Award	+7.5K		7.5K	Mar 1, 2023	Common Stock	7.5K	$4.55	Direct	F1
transaction	CBUS	Stock Option (Right-to-Buy)	Disposed to Issuer	-14.4K	-100%	0	Mar 1, 2023	Common Stock	14.4K	$4.22	Direct	F1
transaction	CBUS	Stock Option (Right-to-Buy)	Award	+14.4K		14.4K	Mar 1, 2023	Common Stock	14.4K	$4.22	Direct	F1
transaction	CBUS	Stock Option (Right-to-Buy)	Disposed to Issuer	-36.4K	-100%	0	Mar 1, 2023	Common Stock	36.4K	$0.30	Direct	F1
transaction	CBUS	Stock Option (Right-to-Buy)	Award	+36.4K		36.4K	Mar 1, 2023	Common Stock	36.4K	$0.30	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Christopher J. Neugent is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.

Content

The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.